An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Launched by UNIVERSITY OF COPENHAGEN · Apr 12, 2022
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying patients with chronic liver diseases that are linked to a condition called hepatic steatosis, which is the buildup of fat in the liver. This buildup can lead to serious problems like inflammation, scarring, and even liver failure. The researchers want to learn more about these liver diseases to help find better ways to diagnose and treat them. They are looking for adult patients aged 18 and older who may have conditions such as non-alcoholic fatty liver disease, autoimmune hepatitis, or hereditary hemochromatosis, among others.
Participants in the study will undergo tests, including a liver biopsy, which is a procedure to take a small sample of liver tissue for examination. By understanding the specific characteristics of these liver conditions, the study hopes to identify important markers that can help doctors in the future. If you or someone you know has a chronic liver disease and is interested in participating, this trial could provide valuable insights into better care and treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients/healthy control participants (age 18 or above) who can give their informed consent
- * Suspected liver disease:
- • non-alcoholic steatohepatitis
- • alcoholic steatohepatitis
- • autoimmune hepatitis
- • primary biliary cholangitis
- • primary sclerosing cholangitis
- • inflammatory bowel disease
- • polycystic ovary syndrome
- • hereditary haemochromatosis
- • chronic pancreatitis
- • cystic fibrosis
- • alpha-1 antitrypsin deficiency
- Exclusion Criteria:
- Patients with:
- • malignant diseases
- • viral hepatitis
- • human immunodeficiency virus
- • contraindications to liver biopsy
About University Of Copenhagen
The University of Copenhagen, a leading research institution in Denmark, is dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, pharmacology, and biotechnology, to design and conduct rigorous clinical studies. Committed to ethical standards and scientific integrity, the University of Copenhagen aims to contribute significantly to the global medical community by facilitating groundbreaking research that addresses pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hvidovre, , Denmark
Patients applied
Trial Officials
Lise L Gluud, Professor
Principal Investigator
Hvidovre University Hospital
Nicolai J Wewer Albrechtsen, MD, PhD
Principal Investigator
NNF Center for Protein Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials